Atractylodin Ameliorates Colitis via PPARα Agonism.
Atractylodin Ameliorates Colitis via PPARα Agonism.
复制标题
DOI:
10.3390/ijms24010802
复制
发表时间:
2023-01-02
影响因子:
5.6
通讯作者:
Im, Eunok
中科院分区:
文献类型:
--
作者:
Heo, Gwangbeom;Kim, Yuju;Kim, Eun-La;Park, Soyeong;Rhee, Sang Hoon;Jung, Jee H. H.;Im, Eunok
Atractylodin is a major compound in the rhizome of Atractylodes lancea, an oriental herbal medicine used for the treatment of gastrointestinal diseases, including dyspepsia, nausea, and diarrhea. Recent studies have shown that atractylodin exerts anti-inflammatory effects in various inflammatory diseases. Herein, we investigated the anti-colitis effects of atractylodin and its molecular targets. We determined the non-cytotoxic concentration of atractylodin (50 μM) using a cell proliferation assay in colonic epithelial cells. We found that pretreatment with atractylodin significantly inhibits tumor necrosis factor-α-induced phosphorylation of nuclear factor-κ-light-chain-enhancer of activated B in HCT116 cells. Through docking simulation analysis, luciferase assays, and in vitro binding assays, we found that atractylodin has an affinity for peroxisome proliferator-activated receptor alpha (PPARα). Daily administration of atractylodin (40 mg/kg) increased the survival rate of mice in a dextran sodium sulfate-induced colitis mouse model. Thus, atractylodin can be a good strategy for colitis therapy through inducing PPARα-dependent pathways.
登录
查看更多内容
影响因子:
--
作者:
Kim SM;Lee B;An HJ;Kim DH;Park KC;Noh SG;Chung KW;Lee EK;Kim KM;Kim DH;Kim SJ;Chun P;Lee HJ;Moon HR;Chung HY
通讯作者:
Chung HY
影响因子:
39.3
作者:
Liu T;Zhang L;Joo D;Sun SC
通讯作者:
Sun SC
影响因子:
4.3
作者:
Zhang, Yi-Zhen;Li, Yong-Yu
通讯作者:
Li, Yong-Yu
影响因子:
3.5
作者:
Tang, Fayin;Fan, Kefeng;Bian, Chuanzhou
通讯作者:
Bian, Chuanzhou
影响因子:
5.6
作者:
Lyu, Zheng;Ji, Xufeng;An, Beiying
通讯作者:
An, Beiying